USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark DOPASTATIN was filed as Word mark on 11/22/2002 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/24/2004.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 78187797 |
| Register number | 2877062 |
| Application date | November 22, 2002 |
| Publication date | March 16, 2004 |
| Entry date | August 24, 2004 |
Trademark owner
65 QUAI GEORGES GORSE
92100 BOULOGNE-BILLANCOURT
FR
92100 BOULOGNE-BILLANCOURT
FR
Trademark representatives
goods and services
1
Chemicals for use in the manufacture of pharmaceutical preparations
5
Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases; laxatives and purgative agents; pharmaceutical preparations for use in the treatment of cardiovascular diseases; pharmaceutical preparations for use in the treatment pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of urological diseases;pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of acromegalia and carcinoid tumors; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for use in the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for use in the treatment of age-related disorders; pharmaceutical preparations for use in the treatment of diabetes, diabetes-related disorders; pharmaceutical preparations for use in the treatment of respiratory disorders; pharmaceutical preparations for use in the treatment of ophthalmological disorders; pharmaceutical preparations against cough; pharmaceutical preparations for use in the treatment of vertigo, nausea, vomiting and migraine; pharmaceutical preparations for use in the treatment of disorders and diseases of the reproductive system; pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin; and Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases; veterinary laxatives and purgative agent; veterinary preparations for use in the treatment of cardiovascular diseases; veterinary preparations for use in the treatment of circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of blood diseases; and veterinary preparations for use in the treatment of muscle disorders
42
Research and development services for chemical and pharmaceutical products
ID: 1378187797